| Financier | Commitments |
|---|---|
| Global Financing Facility | 10.00 |
| IDA Credit | 140.00 |
Investing in Maternal, Child and Adolescent Health
Abstract*
The objective of the Investing in Maternal, Child and Adolescent Health Project in Senegal is to improve utilization of essential reproductive, maternal, neonatal, child and adolescent health and nutrition (RMNCAH-N) services meeting quality standards in Priority Regions. This project consists of four components. Component one will support key interventions to overcome bottlenecks identified as major constraints for health system performance and effective... Show More
Development Objective
The proposed Project Development Objective is to improve utilization of essential reproductive, maternal, neonatal, child and adolescent health and nutrition (RMNCAH-N) services meeting quality standards in Priority Regions.
Key Details
Project Details
P162042
Active
Christophe Lemiere , Aida Gadiaga
Republic of Senegal
May 31, 2018
(as of board presentation)
September 26, 2019
April 14, 2020
US$ 150.00 million
Ministry of Health and Social Action
2020
US$ 150.00 million
B
Not Applicable
June 30, 2025
Yes
BANK APPROVED
June 18, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 140.00 |
| IBRD + IDA Commitment | 140.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | 10.00 |
| Total Project Cost** | 150.00 |
Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Sep 26, 2019 | IDA-64950 | Loan Commitment | 140,000,000.00 |
| May 3, 2023 | IDA-64950 | Loan Disb | 2,331,639.80 |
| Apr 3, 2023 | IDA-64950 | Loan Disb | 704,822.30 |
| Apr 15, 2023 | IDA-64950 | Int Charges | 284.78 |
| Apr 15, 2023 | IDA-64950 | Int Charges | 284.78 |
| Apr 15, 2023 | IDA-64950 | Int Charges | 129,585.31 |
| Apr 15, 2023 | IDA-64950 | Int Charges | 129,585.31 |
| Nov 4, 2022 | IDA-64950 | Loan Disb | 1,376,964.60 |
| Oct 15, 2022 | IDA-64950 | Int Charges | 74,305.33 |
| Oct 15, 2022 | IDA-64950 | Int Charges | 1,591.26 |
| Oct 15, 2022 | IDA-64950 | Int Charges | 1,591.26 |
| Oct 15, 2022 | IDA-64950 | Int Charges | 74,305.33 |
| Oct 12, 2022 | IDA-64950 | Loan Disb | 4,003,278.50 |
| Dec 21, 2022 | IDA-64950 | Loan Disb | 2,262,189.00 |
| Dec 30, 2022 | IDA-64950 | Loan Disb | 1,104,112.10 |
| Dec 28, 2021 | IDA-64950 | Loan Disb | 1,759,290.00 |
| Mar 1, 2022 | IDA-64950 | Loan Disb | 1,367,151.20 |
| Aug 3, 2022 | IDA-64950 | Loan Disb | 911,135.20 |
| Jan 10, 2022 | IDA-64950 | Loan Disb | 464,906.78 |
| Dec 8, 2021 | IDA-64950 | Loan Disb | 541,822.50 |
| Apr 15, 2022 | IDA-64950 | Int Charges | 32.43 |
| Apr 15, 2022 | IDA-64950 | Int Charges | 32.43 |
| Apr 15, 2022 | IDA-64950 | Int Charges | 26,546.89 |
| Apr 15, 2022 | IDA-64950 | Int Charges | 26,546.89 |
| Jun 17, 2022 | IDA-64950 | Loan Disb | 1,663,595.20 |
| May 24, 2022 | IDA-64950 | Loan Disb | 1,516,619.60 |
| Mar 8, 2022 | IDA-64950 | Loan Disb | 725,145.50 |
| Dec 14, 2021 | IDA-64950 | Loan Disb | 3,365,011.00 |
| May 2, 2022 | IDA-64950 | Loan Disb | 2,617,829.00 |
| Jun 24, 2022 | IDA-64950 | Loan Disb | 1,584,102.40 |
| Apr 20, 2022 | IDA-64950 | Loan Disb | 4,795,592.50 |
| Oct 15, 2021 | IDA-64950 | Int Charges | 13,344.19 |
| Oct 15, 2021 | IDA-64950 | Int Charges | 13,344.19 |
| Apr 16, 2021 | IDA-64950 | Loan Cancel | 20,000,000.00 |
| Apr 15, 2021 | IDA-64950 | Int Charges | 13,718.57 |
| Apr 15, 2021 | IDA-64950 | Int Charges | 13,718.57 |
| Apr 14, 2020 | IDA-64950 | Loan Disb | 412,673.22 |
| Oct 16, 2020 | IDA-64950 | Loan Disb | 3,158,576.50 |
| Oct 16, 2020 | IDA-64950 | Int Charges | 1,666.25 |
| Oct 16, 2020 | IDA-64950 | Int Charges | 1,666.25 |
| Apr 2, 2024 | IDA-64950 | Loan Disb | 3,098,783.00 |
| Jun 6, 2024 | IDA-64950 | Loan Disb | 935,812.00 |
| Aug 26, 2024 | IDA-64950 | Loan Disb | 2,100,767.00 |
| Jul 17, 2024 | IDA-64950 | Loan Disb | 2,689,945.20 |
| Jun 20, 2024 | IDA-64950 | Loan Disb | 1,677,705.60 |
| Feb 2, 2024 | IDA-64950 | Loan Disb | 273,900.97 |
| Jan 31, 2024 | IDA-64950 | Loan Disb | 2,851,746.80 |
| Aug 8, 2024 | IDA-64950 | Loan Disb | 3,148,406.20 |
| Apr 26, 2024 | IDA-64950 | Int Charges | 2,378.42 |
| Apr 26, 2024 | IDA-64950 | Int Charges | 2,378.42 |
| Apr 26, 2024 | IDA-64950 | Int Charges | 249,222.45 |
| Apr 26, 2024 | IDA-64950 | Int Charges | 249,222.45 |
| Apr 10, 2024 | IDA-64950 | Loan Disb | 730,642.10 |
| Mar 14, 2024 | IDA-64950 | Loan Disb | 2,046,329.40 |
| Apr 19, 2024 | IDA-64950 | Loan Disb | 2,788,328.80 |
| Oct 5, 2023 | IDA-64950 | Loan Disb | 4,254,569.50 |
| Jun 10, 2024 | IDA-64950 | Loan Disb | 3,246,440.50 |
| Jan 16, 2024 | IDA-64950 | Loan Disb | 3,939,331.50 |
| Jan 11, 2024 | IDA-64950 | Loan Disb | 4,577,167.50 |
| Jan 11, 2024 | IDA-64950 | Loan Disb | 2,634,543.50 |
| Nov 10, 2023 | IDA-64950 | Loan Disb | 909,027.90 |
| Oct 15, 2023 | IDA-64950 | Int Charges | 3,417.08 |
| Oct 15, 2023 | IDA-64950 | Int Charges | 3,417.08 |
| Oct 15, 2023 | IDA-64950 | Int Charges | 177,658.33 |
| Oct 15, 2023 | IDA-64950 | Int Charges | 177,658.33 |
| Jun 5, 2023 | IDA-64950 | Loan Disb | 1,522,068.10 |
| Jun 28, 2023 | IDA-64950 | Loan Disb | 5,191,247.00 |
| Jun 28, 2023 | IDA-64950 | Loan Disb | 2,253,367.20 |
| Aug 3, 2023 | IDA-64950 | Loan Disb | 1,446,734.00 |
| Sep 5, 2023 | IDA-64950 | Loan Disb | 1,642,410.90 |
| Jan 26, 2023 | IDA-64950 | Loan Disb | 741,292.70 |
| Jan 11, 2023 | IDA-64950 | Loan Disb | 1,938,425.80 |
| Feb 22, 2023 | IDA-64950 | Loan Disb | 696,334.56 |
| Feb 28, 2023 | IDA-64950 | Loan Disb | 2,560,736.20 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Safeguards Rating | Moderately Satisfactory | 2024-12-19 |
| Financial Management | Moderately Unsatisfactory | 2024-12-19 |
| Project Management | Satisfactory | 2024-12-19 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-12-19 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-12-19 |
| Progress towards achievement of PDO | Moderately Unsatisfactory | 2024-12-19 |
| Procurement | Moderately Satisfactory | 2024-12-19 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Utilization of health services by patients covered by a community-based insurance mechanism Value 15.00 45.00 40.00 Date July 8, 2019 June 5, 2024 December 31, 2024 Comment Completion rate for ANCs Value 55.50 68.40 81.00 Date December 28, 2018 June 5, 2024 December 31, 2024 Comment Percentage of children under 5 suffering from childhood stunting in Senegal Value 17.00 17.50 10.00 Date June 30, 2017 June 5, 2024 December 31, 2024 Comment Contraceptive prevalence rate (Percentage) Value 26.00 25.60 36.00 Date July 8, 2019 June 5, 2024 December 31, 2024 Comment Percentage of children under 5 suffering from childhood stunting in the priority regions Value 22.30 18.70 10.00 Date December 31, 2019 June 5, 2024 December 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Adolescent girls not pregnant among cash transfer beneficiaries Value 0.00 100.00 96.00 Date May 30, 2019 June 5, 2024 December 31, 2024 Comment Number of vulnerable beneficiaries (children aged 0-5) covered by the CBHIS Value 0.00 415277.00 954465.00 Date May 30, 2019 June 5, 2024 December 31, 2024 Comment Utilisation rate of modern contraceptive methods by adolescent girls in a relationship, aged 15-19 Value 8.00 9.80 18.50 Date September 19, 2018 June 5, 2024 December 31, 2024 Comment Number of vulnerable beneficiaries (pregnant women) covered by the CBHIS Value 0.00 44321.00 184830.00 Date December 31, 2020 June 5, 2024 December 31, 2024 Comment Women benefiting from revolving credit Value 0.00 0.00 9000.00 Date January 4, 2021 December 29, 2023 December 31, 2024 Comment Completion rate of health facilities data reports Value 91.50 25.10 99.00 Date May 30, 2019 June 5, 2024 December 31, 2024 Comment Maturity level achieved on the WHO Global Benchmarking Tool for evaluation of national regulatory systems of medical products Value 1.00 3.00 3.00 Date January 4, 2021 June 5, 2024 December 31, 2024 Comment Percentage of deliveries in health facilities Value 60.00 92.00 80.00 Date December 31, 2019 June 5, 2024 December 31, 2024 Comment Nurses per 5,000 Population Value 0.34 0.67 1.00 Date January 4, 2021 June 5, 2024 December 31, 2024 Comment Midwives for 1,500 women of reproductive age Value 0.78 1.19 1.00 Date January 4, 2021 June 5, 2024 December 31, 2024 Comment Functional health posts in the intervention area Value 572.00 603.00 616.00 Date January 3, 2022 June 5, 2024 December 31, 2024 Comment People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement) Value 0.00 0.00 0.00 Date Comment Number of children immunized Value 0.00 594877.00 826108.00 Date July 8, 2019 June 5, 2024 December 31, 2024 Comment Number of women and children who have received basic nutrition services Value 0.00 1482673.00 1148169.00 Date September 18, 2018 June 5, 2024 December 31, 2024 Comment Number of deliveries attended by skilled health personnel Value 0.00 532476.00 869587.00 Date September 18, 2018 June 5, 2024 December 31, 2024 Comment Adolescent girls who benefited from cash transfers Value 0.00 900.00 49391.00 Date July 8, 2019 June 5, 2024 December 31, 2024 Comment Number of beneficiaries of the CBHIS Value 816393.00 4932038.00 2837532.00 Date December 31, 2018 June 18, 2024 December 31, 2024 Comment People who have received essential health, nutrition, and population (HNP) services Value 0.00 2610026.00 2843864.00 Date July 8, 2019 June 5, 2024 December 31, 2024 Comment